Karen L. Smith - Insider Trading & Ownership

Location
C/O Jazz Pharmaceuticals Plc, 5 Th Fl, Waterloo Exchange, Waterloo Rd, Dublin L2 4, Ireland
Summary
The estimated net worth of Karen L. Smith is at least $462K dollars as of June 16, 2025. Karen L. Smith is the Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $209K. Karen L. Smith is the Chief Medical Officer of Quince Therapeutics, Inc. and owns shares of Quince Therapeutics, Inc. (QNCX) stock worth about $183K. Karen L. Smith is the Director of SANGAMO THERAPEUTICS, INC and owns shares of SANGAMO THERAPEUTICS, INC (SGMO) stock worth about $47K. Karen L. Smith is the EVP, Chief Medical Officer of Emergent BioSolutions Inc. and owns shares of Emergent BioSolutions Inc. (EBS) stock worth about $21.6K. Karen L. Smith is the Director of Skye Bioscience, Inc. and owns shares of Skye Bioscience, Inc. (SKYE) stock worth about $1.19K.
Signature
/s/ Prathyusha Duraibabu, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Karen L. Smith

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AUPH Aurinia Pharmaceuticals Inc. Director $209K -$44.2K -17.4% Nov 21, 2024
QNCX Quince Therapeutics, Inc. Chief Medical Officer $183K Feb 1, 2023
SGMO SANGAMO THERAPEUTICS, INC Director $47K Jun 12, 2025
EBS Emergent BioSolutions Inc. EVP, Chief Medical Officer $21.6K May 7, 2021
SKYE Skye Bioscience, Inc. Director $1.19K Feb 24, 2025
XLRN ACCELERON PHARMA INC Director Nov 19, 2021
ATRS ANTARES PHARMA, INC. Director May 24, 2022
CNTX Context Therapeutics Inc. Director Jun 12, 2025
TRML Tourmaline Bio, Inc. Director Jun 13, 2023

Insider Transactions Reported by Karen L. Smith:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.